Brigitta Derendinger

491 total citations
17 papers, 129 citations indexed

About

Brigitta Derendinger is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Brigitta Derendinger has authored 17 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Brigitta Derendinger's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (4 papers). Brigitta Derendinger is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (4 papers). Brigitta Derendinger collaborates with scholars based in South Africa, United States and Switzerland. Brigitta Derendinger's co-authors include Grant Theron, Robin M. Warren, Margaretha de Vos, Tania Dolby, Paul D. van Helden, John Simpson, Lawrence J. Wangh, Johann M. van Zyl, J. E. Rice and H. I. Seifart and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Brigitta Derendinger

15 papers receiving 125 citations

Peers

Countries citing papers authored by Brigitta Derendinger

Since Specialization

Citations

This map shows the geographic impact of Brigitta Derendinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitta Derendinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitta Derendinger more than expected).

Fields of papers citing papers by Brigitta Derendinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitta Derendinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitta Derendinger. The network helps show where Brigitta Derendinger may publish in the future.

Co-authorship network of co-authors of Brigitta Derendinger

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitta Derendinger. A scholar is included among the top collaborators of Brigitta Derendinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitta Derendinger. Brigitta Derendinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Diagnostic Accuracy of LiquidArray MTB-XDR VER 1.0 for the Detection of Mycobacterium tuberculosis Complex, Fluoroquinolone, Amikacin, Ethambutol, and Linezolid Susceptibility 2024 ·Clinical Infectious Diseases ·(unknown), (unknown), Brigitta Derendinger, Rouxjeane Venter, Elizabeth M. Streicher, (unknown), Yonas Ghebrekristos, (unknown), Morten Rühwald, Robin M. Warren, Adam Penn‐Nicholson, Grant Theron, Margaretha de Vos	1
2	Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study 2024 ·The Lancet Global Health ·Byron W P Reeve, (unknown), Hridesh Mishra, Zaida Palmer, (unknown), (unknown), (unknown), (unknown), C Naidoo, Brigitta Derendinger, Gerhard Walzl, Stephanus T. Malherbe, Paul D. van Helden, Fred C. Semitala, Christina Yoon, Rishi K Gupta, Mahdad Noursadeghi, Robin M. Warren, Grant Theron	6
3	C-Reactive Protein–based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study 2024 ·American Journal of Respiratory and Critical Care Medicine ·Brigitta Derendinger, (unknown), (unknown), Deepa Shankar, (unknown), (unknown), (unknown), William Worodria, Charles Yu, Nguyen Viet Nhung, (unknown), Grant Theron, Patrick Phillips, Payam Nahid, Claudia M. Denkinger, Adithya Cattamanchi, Christina Yoon	0
4	Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation 2023 ·The Lancet Microbe ·(unknown), Natalie Beylis, Chad M. Centner, Rouxjeane Venter, Brigitta Derendinger, (unknown), (unknown), (unknown), (unknown), (unknown), Tania Dolby, Florian M. Marx, Shaheed Vally Omar, Robin M. Warren, Grant Theron	6
5	Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis 2022 ·Journal of Molecular Diagnostics ·Brigitta Derendinger, Margaretha de Vos, (unknown), Rouxjeane Venter, John Metcalfe, Yonas Ghebrekristos, (unknown), Tania Dolby, Natalie Beylis, Robin M. Warren, Grant Theron	2
6	Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory 2022 ·Clinical Infectious Diseases ·(unknown), Margaretha de Vos, Brigitta Derendinger, Elizabeth M. Streicher, Tania Dolby, (unknown), (unknown), Robin M. Warren, Grant Theron	8
7	Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance 2021 ·Clinical Microbiology and Infection ·Anzaan Dippenaar, Brigitta Derendinger, Tania Dolby, Natalie Beylis, Paul D. van Helden, Grant Theron, Robin M. Warren, Margaretha de Vos	13
8	Emergence of resistance to bedaquiline 2021 ·International Journal of Mycobacteriology ·Margaretha de Vos, Serej D. Ley, (unknown), Brigitta Derendinger, Anzaan Dippenaar, Melanie Grobbelaar, Anja Reuter, Johnny Daniels, Tania Dolby, (unknown), Marco Schito, Annelies Van Rie, (unknown), (unknown), John S. Metcalf, James E. Posey, Grant Theron, Helen Cox, Robin M. Warren	0
9	Melting the eis : Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New eis Promoter Variants 2021 ·Antimicrobial Agents and Chemotherapy ·Serej D. Ley, (unknown), Elizabeth M. Streicher, Yuri F. van der Heijden, (unknown), Brigitta Derendinger, (unknown), Sébastien Gagneux, Robin M. Warren, Grant Theron, Margaretha de Vos	1
10	High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South Africa 2021 ·International Journal of Mycobacteriology ·Brigitta Derendinger, Anzaan Dippenaar, Margaretha de Vos, (unknown), (unknown), Tania Dolby, Claudia Spies, Leen Rigouts, John Metcalfe, David M. Engelthaler, Robin M. Warren, Helen Cox, Grant Theron	4
11	Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk 2020 ·Scientific Reports ·Rouxjeane Venter, (unknown), Brigitta Derendinger, (unknown), Margaretha de Vos, Tania Dolby, (unknown), Robin M. Warren, Grant Theron	7
12	Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana 2019 ·Pathogens ·(unknown), (unknown), Brigitta Derendinger, Serej D. Ley, Elizabeth M. Streicher, (unknown), Lucy Mupfumi, Margaret Mokomane, (unknown), (unknown), (unknown), Ishmael Kasvosve, Sikhulile Moyo, Robin M. Warren, Simani Gaseitsiwe	5
13	Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus) 2018 ·Scientific Reports ·Brigitta Derendinger, Margaretha de Vos, Ruvandhi R. Nathavitharana, Tania Dolby, John Simpson, Paul D. van Helden, Robin M. Warren, Grant Theron	7
14	Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis 2018 ·Journal of Clinical Microbiology ·Margaretha de Vos, Brigitta Derendinger, Tania Dolby, John Simpson, Paul D. van Helden, J. E. Rice, Lawrence J. Wangh, Grant Theron, Robin M. Warren	38
15	EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA 2018 ·Russian Journal of Infection and Immunity ·Margaretha de Vos, Serej D. Ley, Brigitta Derendinger, Anzaan Dippenaar, Melanie Grobbelaar, Anja Reuter, Johnny Daniels, (unknown), Grant Theron, James E. Posey, (unknown), Helen Cox	3
16	Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping 2017 ·Scientific Reports ·Rouxjeane Venter, Brigitta Derendinger, Margaretha de Vos, (unknown), (unknown), John Simpson, (unknown), (unknown), Paul D. van Helden, Robin M. Warren, Grant Theron	13
17	Comparative diffusion of drugs through bronchial tissue 2008 ·International Journal of Pharmaceutics ·Johann M. van Zyl, Brigitta Derendinger, H. I. Seifart, Pieter van der Bijl	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact